Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 14 Oct 2024

Antagonistic roles of cGAS/STING signaling in colorectal cancer chemotherapy

in Cancer Molecular Targets and Therapeutics

Beiyuan Liang
Xuanxuan Xing
Hayden Storts
Zhen Ye
Hazel Claybon
Ryan Austin
Rachel Ding
Bei Liu
Haitao Wen
Wayne O. Miles

Frontiers in Oncology

doi 10.3389/fonc.2024.1441935

3,734 views
2 citations

Original Research

Published on 14 Oct 2024

Integration of ubiquitination-related genes in predictive signatures for prognosis and immunotherapy response in sarcoma

in Cancer Molecular Targets and Therapeutics

Haotian Qin
Tiantian Qi
Juan Xu
Tianbing Wang
Hui Zeng
Jun Yang
Fei Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1446522

2,702 views
3 citations

Review

Published on 11 Oct 2024

Lung cancer cell-derived exosomes: progress on pivotal role and its application in diagnostic and therapeutic potential

in Cancer Molecular Targets and Therapeutics

Aimi Syamima Abdul Manap
Faith Malambo Ngwenya
Meilarshny Kalai Selvan
Syarafina Arni
Fathimath Hishma Hassan
Ammar Danish Mohd Rudy
Nurul Nadiah Abdul Razak

Frontiers in Oncology

doi 10.3389/fonc.2024.1459178

3,480 views
5 citations

Original Research

Published on 11 Oct 2024

Association of mutation profiles with metastasis in patients with non-small cell lung cancer

in Cancer Molecular Targets and Therapeutics

Yingxue Li
Zheng Zheng
Li Wang
Lin Han
Ying Du
Xuedong Zhang
Xia Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1451576

2,168 views
1 citation

Original Research

Published on 11 Oct 2024

Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patients

in Cancer Molecular Targets and Therapeutics

Yuya Hirasawa
Yutaro Kubota
Emiko Mura
Risako Suzuki
Toshiaki Tsurui
Nana Iriguchi
Tomoyuki Ishiguro
Ryotaro Ohkuma
Masahiro Shimokawa
Hirotsugu Ariizumi

Frontiers in Oncology

doi 10.3389/fonc.2024.1449941

1,549 views

Original Research

Published on 07 Oct 2024

RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoides

in Cancer Molecular Targets and Therapeutics

Maria Danielsen
Thomas Emmanuel
Morten Muhlig Nielsen
Lise Maria Lindahl
Maria Gluud
Niels Ødum
Line Raaby
Torben Steiniche
Lars Iversen
Rikke Bech

Frontiers in Oncology

doi 10.3389/fonc.2024.1421443

1,828 views
1 citation

Original Research

Published on 07 Oct 2024

POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma

in Cancer Molecular Targets and Therapeutics

Laura del Puerto-Nevado
María J. Fernández-Aceñero
Arancha Cebrián
Yuliia Fatych
Luis I. Díez-Valladares
Elia Pérez-Aguirre
Sofía de la Serna
Alejandra García-Botella
Javier Martínez-Useros
Jesús García-Foncillas

Frontiers in Oncology

doi 10.3389/fonc.2024.1433179

1,788 views
1 citation

Original Research

Published on 03 Oct 2024

Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs

in Cancer Molecular Targets and Therapeutics

Terri V. Cornforth
Nathifa Moyo
Suzanne Cole
Emily P. S. Lam
Tatiana Lobry
Ron Wolchinsky
Angharad Lloyd
Katarzyna Ward
Eleanor M. Denham
Giulia Masi

Frontiers in Oncology

doi 10.3389/fonc.2024.1419528

4,290 views
7 citations

Original Research

Published on 30 Sep 2024

Potential tumor-specific antigens and immune landscapes identification for mRNA vaccine in thyroid cancer

in Cancer Molecular Targets and Therapeutics

Xiaoning Wang
Guixin Wang
Qiaoqiao Xu
Yingxi Li
Wenbin Song
Zhaoyi Liu
Yao Tian
Li Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1480028

2,201 views
1 citation

Editorial

Published on 30 Sep 2024

Editorial: Multimodality therapy for older cancer patients

in Cancer Molecular Targets and Therapeutics

Nam P. Nguyen
Mohammad Mohammadianpanah
Meritxell Arenas
Vincent Vinh-Hung

Frontiers in Oncology

doi 10.3389/fonc.2024.1487783

744 views

Review

Published on 30 Sep 2024

Applications of cerebrospinal fluid circulating tumor cells and circulating tumor-derived DNA in diagnosis, prognosis, and personalized treatment of CNS metastases

in Cancer Molecular Targets and Therapeutics

Elena Pentsova

Frontiers in Oncology

doi 10.3389/fonc.2024.1409383

1,937 views
1 citation

Case Report

Published on 26 Sep 2024

Case report: Tenosynovial giant cell tumor

in Cancer Molecular Targets and Therapeutics

Anke Fähnrich
Zhala Gasimova
Yamil Maluje
Fabian Ott
Helen Sievert
Stephanie Fliedner
Niklas Reimer
Axel Künstner
Niklas Gebauer
Maxim Kebenko

Frontiers in Oncology

doi 10.3389/fonc.2024.1445427

3,045 views

Original Research

Published on 19 Sep 2024

Identification of potential biomarkers for lung adenocarcinoma: a study based on bioinformatics analysis combined with validation experiments

in Cancer Molecular Targets and Therapeutics

Chuchu Zhang
Ying Liu
Yingdong Lu
Zehui Chen
Yi Liu
Qiyuan Mao
Shengchuan Bao
Ge Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1425895

2,579 views

Mini Review

Published on 17 Sep 2024

Bridging the gap: advancing cancer cell culture to reveal key metabolic targets

in Cancer Molecular Targets and Therapeutics

Marjolein M. G. Kes
Celia R. Berkers
Jarno Drost

Frontiers in Oncology

doi 10.3389/fonc.2024.1480613

2,395 views
1 citation

Original Research

Published on 13 Sep 2024

Cleft lip and palate transmembrane protein 1-like is a putative regulator of tumorigenesis and sensitization of cervical cancer cells to cisplatin

in Cancer Molecular Targets and Therapeutics

Weipeng Liu
Fengdan Huang
Yueting Yao
Yan Liang
Zhiling Yan
Lili Guo
Xinwen Zhang
Li Shi
Yufeng Yao

Frontiers in Oncology

doi 10.3389/fonc.2024.1440906

1,843 views

Review

Published on 13 Sep 2024

Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance

in Cancer Molecular Targets and Therapeutics

Fatemeh Yazarlou
Ivan Martinez
Leonard Lipovich

Frontiers in Oncology

doi 10.3389/fonc.2024.1437542

5,232 views